Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
cefixime (cefixime trihydrate)
Alkaloid AD Skopje
J01DD08
cefixime (cefixime trihydrate)
100mg/5ml
powder for oral suspension
53g powder in 100ml glass bottle and 5ml measuring spoon
Prescription
Registered
2022-11-03
PANCEF 100 mg/5 ml powder for oral suspension Summary of Product Characteristics 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PANCEF 100 mg/5 ml powder for oral suspension. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 5 ml (1 graduated spoon) of prepared suspension contains 111.9 mg of cefixime trihydrate, corresponding to 100 mg of cefixime.). Excipients with known effect: Sucrose 2.517 g/5 ml Sodium benzoate (E 211) 2.5 mg/5 ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM * Powder for oral suspension. Almost white to pale yellow powder. The reconstituted suspension appears as almost white to pale yellow viscous liquid. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pancef is indicated for the treatment of infections caused by microorganisms sensitive to cefixime, as follows: acute upper respiratory tract infections (pharyngo-tonsillitis, sinusitis); otitis media acuta; lower respiratory tract infections (acute bronchitis, acute exacerbation of chronic bronchitis, tracheobronchitis, pneumonia); uncomplicated and complicated urinary tract infections, including acute pyelonephritis; uncomplicated gonorrhea (cervical/urethral); Consideration should be given to official guidance on the appropriate use of antibacterial agents. PANCEF 100 mg/5 ml powder for oral suspension Summary of Product Characteristics 2 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology _ Paediatric population _ _ _Children below 10 years old or_ _weighing less than 50 kg: _8 mg/kg daily administered as a single oral dose, or divided in two equal doses of (4 mg/kg every 12 hours). As a general guide for prescribing in children the following daily doses in terms of volume of oral suspension are suggested: 6 months up to 1 year: 2.5 ml to 5.0 ml daily. Children 1-4 years: 5 ml daily Children 5-10 years: 10 ml daily The safety and efficacy of cefixime has not been established in children under 6 months. _Children weighing more than 50 kg or older than 10 years_ should be tr Read the complete document